Executive Committee:
- Paul Petrelli, President, Jazz Pharmaceuticals (Chairman)
- Roberto Bellini, President & CEO, Bellus Health (Vice Chair)
- Kevin Leshuk, General Manager, Celgene Inc. (Treasurer)
- Andrew Casey, President & CEO, BIOTECanada (Secretary)
Directors:
- Chris Aiello, General Manager, Bioverativ
- Brian Bloom, Chairman & CEO, Bloom Burton & Co.
- Neal Carter, President & Founder, Okanagan Specialty Fruits
- Natalie Dakers, President & CEO, Accel-Rx Health Sciences
- John Helou, President & CEO, Pfizer Canada
- Brian Hilberdink, President, Novo Nordisk Canada Inc.
- Alok Kanti, General Manager, Bayer Canada
- A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada
- Gordon McCauley, President and CEO, CDRD
- John Norman, Partner, Gowling WLG (Canada) LLP
- Sanj Singh, President & CEO, Temple Therapeutics B.V.
- Oliver Technow, CEO, BioVectra Inc.
- Shermaine Tilley, Managing Partner, CTI Life Sciences Fund
- Eric Tse, Head of Canada, Shire
- Dan Wattier, CEO, ImStar Therapeutics
